Thus, Eser and coworkers have provided evidence that PI3K, as well as 3-phosphoinositide-dependent kinase 1 (PDK1) are activated in tumor pancreatic neoplasia (including preneoplastic lesions), as well as in KRAS-driven murine pancreatic cancer [118]. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.